Rekombinanter VEGF (Bevacizumab Biosimilar) Antikörper

Produktnummer ABIN7487763

Der Maus Chimeric Anti-VEGF (Bevacizumab Biosimilar)-Antikörper wurde für FACS, ELISA, BR, IP und WB validiert. Er ist geeignet, VEGF (Bevacizumab Biosimilar) in Proben von Human zu detektieren.

Kurzübersicht für Rekombinanter VEGF (Bevacizumab Biosimilar) Antikörper (ABIN7487763)

Target: VEGF (Bevacizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Chimeric

Konjugat: Dieser VEGF (Bevacizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)

Produktdetails anti-VEGF (Bevacizumab Biosimilar) Antikörper

Verwendungszweck: Anti-VEGF [Bevacizumab], Mouse IgG2a, kappa

Spezifität: This antibody binds native and reduced human VEGF (isoform 165).

Produktmerkmale:

Original Species of Ab: Human

Original Format of Ab: IgG1

Aufreinigung: Protein A affinity purified

Immunogen: Recombinant human VEGF.

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Kommentare:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu VEGF (Bevacizumab Biosimilar)

Target: VEGF (Bevacizumab Biosimilar)

Hintergrund: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692